Latest News

Finerenone Approved in EU for HF with LVEF ≥40%
Written by: Heart Failure Academy
Finerenone Approved in EU for HF with LVEF ≥40%
Smartwatch Data Predicts Heart Failure Exacerbations
Written by: CFR Journal
Smartwatch Data Predicts Heart Failure Exacerbations
OPTION-STEMI: Staged Revascularisation for STEMI with HF
Written by: Cardiac Failure Review
OPTION-STEMI: Staged Revascularisation for STEMI with HF
LBBP Superior to BiVP for HF Outcomes in HeartSync-LBBP
Written by: Arrhythmia and Electrophysiology Review
LBBP Superior to BiVP for HF Outcomes in HeartSync-LBBP
TEER Linked to Better Outcomes in AFMR Patients
Written by: Transcatheter Academy
TEER Linked to Better Outcomes in AFMR Patients
Aficamten Superior to Metoprolol in oHCM: MAPLE-HCM
Written by: CFR Journal Radcliffe Cardiology
Aficamten Superior to Metoprolol in oHCM: MAPLE-HCM
AI-ECG Enhances Heart Failure Risk Prediction
Written by: Arrhythmia Academy
AI-ECG Enhances Heart Failure Risk Prediction
Early SGLT2i/MRA Use Benefits Suspected HF Patients
Written by: Cardiac Failure Review Journal
Early SGLT2i/MRA Use Benefits Suspected HF Patients
Plaque Burden on CCTA Predicts MACE in Early CAD
Written by: Radcliffe Vascular
Plaque Burden on CCTA Predicts MACE in Early CAD
February’s Top 10 Cardiology Resources: Videos and Essential Reads
Written by: Radcliffe Cardiology
February’s Top 10 Cardiology Resources: Videos and Essential Reads

External news

Written by: Academic - advance access - HF
Research Letter: Prognostic impact of MRI-derived indexed left ventricular end-diastolic volume (LVEDVi) in individuals with preserved and reduced LV ejection fraction without heart failure in the UK Biobank
Written by: Academic - open access - HF
Changes in Upright Hemodynamics Preceding Heart Failure Events and Other Hospitalizations
Written by: Academic - advance access - HF
Changes in Upright Hemodynamics Preceding Heart Failure Events and Other Hospitalizations
Written by: Academic - advance access - HF
Genetic Determinants of Severity and Recurrence in Arrhytmia-Induced Cardiomyopathy
Written by: Academic - advance access - HF
Cost-effectiveness of finerenone in heart failure with mildly reduced or preserved ejection fraction – Insights from FINEARTS-HF
Written by: Academic - advance access - HF
Epicardial adipose tissue is associated with impaired outcomes in genotype-positive hypertrophic cardiomyopathy
Written by: Academic - open access - HF
Go with the flow: targeting the lymphatic system in acute decompensated heart failure – DELTA-HF trial
Written by: Academic - open access - HF
Epicardial adipose tissue is associated with impaired outcomes in genotype-positive hypertrophic cardiomyopathy
Written by: Academic - advance access - HF
Go with the flow: targeting the lymphatic system in acute decompensated heart failure – DELTA-HF trial
Written by: Academic - advance access - HF
Cardiovascular events after acute myocardial infarction complicated by low ejection fraction and/or congestion: a landmark analysis of the PARADISE-MI trial